Amyris Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $2.7500
- Today's High:
- $3.0250
- Open Price:
- $2.9800
- 52W Low:
- $1.47
- 52W High:
- $14.52
- Prev. Close:
- $2.9400
- Volume:
- 3223748
Company Statistics
- Market Cap.:
- $0.893 billion
- Book Value:
- 0.798
- Revenue TTM:
- $0.236 billion
- Operating Margin TTM:
- -200.2%
- Gross Profit TTM:
- $0.093 billion
- Gross Profit TTM:
- $0.093 billion
- Profit Margin:
- -90.2%
- Return on Assets TTM:
- -47.7%
- Return on Equity TTM:
- -532%
Company Profile
Amyris Inc had its IPO on 2010-09-28 under the ticker symbol AMRS.
The company operates in the LIFE SCIENCES sector and INDUSTRIAL ORGANIC CHEMICALS industry. Amyris Inc has a staff strength of 0 employees.
Stock update
Shares of Amyris Inc opened at $2.98 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $2.75 - $3.03, and closed at $2.75.
This is a -6.46% slip from the previous day's closing price.
A total volume of 3,223,748 shares were traded at the close of the day’s session.
In the last one week, shares of Amyris Inc have slipped by -8.33%.
Amyris Inc's Key Ratios
Amyris Inc has a market cap of $0.893 billion, indicating a price to book ratio of 3.001 and a price to sales ratio of 3.792.
In the last 12-months Amyris Inc’s revenue was $0.236 billion with a gross profit of $0.093 billion and an EBITDA of $-0.459 billion. The EBITDA ratio measures Amyris Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Amyris Inc’s operating margin was -200.2% while its return on assets stood at -47.7% with a return of equity of -532%.
In Q2, Amyris Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 24.6%.
Amyris Inc’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- -0.03
Its diluted EPS in the last 12-months stands at $-0.387 per share while it has a forward price to earnings multiple of - and a PEG multiple of -0.03. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Amyris Inc’s profitability.
Amyris Inc stock is trading at a EV to sales ratio of 6.86 and a EV to EBITDA ratio of -9.18. Its price to sales ratio in the trailing 12-months stood at 3.792.
Amyris Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Amyris Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Amyris Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Amyris Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Amyris Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Amyris Inc paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $2.75
- 52-Week High
- $14.52
- 52-Week Low
- $1.47
- Analyst Target Price
- $11.76
Amyris Inc stock is currently trading at $2.75 per share. It touched a 52-week high of $14.52 and a 52-week low of $14.52. Analysts tracking the stock have a 12-month average target price of $11.76.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Amyris Inc
Similar Industry Stocks (INDUSTRIAL ORGANIC CHEMICALS)
Most Active
Top Gainers
Top Losers
About
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of natural and sustainable ingredients in Europe, the United States, Asia, Brazil and internationally. The company is headquartered in Emeryville, California.